Glycosylated hemoglobin as a predictor of mortality in severe pneumonia by COVID-19.

Jesús Salvador Sánchez DíazKarla Gabriela Peniche MoguelEduardo Alberto González EscuderoLuis Del Carpio OrantesEnrique Monares ZepedaOrlando Rubén Perez NietoEder Ivan Zamarron LopezErnesto Deloya TomasFernando Enrique Estrada GonzalezJesús Díaz TorresDiego Escarraman MartinezManuel Alberto Guerrero Gutierrez

Published in: Expert review of respiratory medicine (2021)

The 28-day probability of survival in patients with severe SARS-CoV-2 pneumonia with IMV in the ICU is lower when the HbA1c level is ≥6.5% on admission.

Keyphrases

sars cov
early onset
respiratory syndrome coronavirus
coronavirus disease
intensive care unit
emergency department
drug induced
type diabetes
cardiovascular disease
mechanical ventilation
free survival